Arctium lappa L. 叶子通过调节三碳酸循环和抑制STAT3/NF-кB信号传递来缓解阿尔茨海默氏症等病理
Ruixue Zhang1,2,3, Shouchen Mu1,2,3, Shimeng Zhang1,2,3
1Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China.
Plant foods for human nutrition (Dordrecht, Netherlands)
|December 19, 2025
概括
叶在治疗阿尔茨海默病 (AD) 方面表现有前途. 这项研究发现,白叶通过减少炎症和代谢问题,在AD模型大鼠中改善了记忆和认知能力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 传统中国医药 传统中国医药
背景情况:
- 目前的阿尔茨海默病 (AD) 治疗方法的疗效和副作用有限.
- 在中国传统医学中,叶具有清除热量和抗炎性质.
- 鱼叶对阿尔茨海默病的神经保护潜力仍然在很大程度上未被探索.
研究的目的:
- 在阿尔茨海默病 (AD) 模型大鼠中研究鱼叶的神经保护作用.
- 为了确定白叶是否可以缓解神经炎症并延迟AD的进展.
- 阐明叶在AD中的作用的基本机制.
主要方法:
- 在AD模型大鼠中使用叶干预措施.
- 对认知功能,学习和记忆的评估.
- 对海马体组织进行基因病理学分析,检测病变,神经元损失,β-粉样蛋白和tau蛋白.
- 代谢学研究以确定调节的代谢途径.
- 西部斑点分析检查信号通路 (STAT3 / NF-κB) 和蛋白质表达.
主要成果:
- 在AD模型大鼠中,白叶干预显著改善了学习,记忆和认知障碍.
- 组织病理学揭示了海马病变的缓解,神经元损失,粉样β积累和Tau酸化.
- 代谢学确定了三碳酸 (TCA) 循环是叶调节的关键途径.
- 西部斑点分析表明,抑制STAT3 / NF-κB信号通路并减少炎症蛋白质表达.
结论:
- 叶在改善AD的认知缺陷和神经炎症方面显示出显著的治疗潜力.
- 这项研究表明,叶通过解决代谢失调和抑制炎症途径来延缓AD的进展.
- 叶是阿尔茨海默病治疗药物的进一步研究和开发的有希望的自然候选者.
更多相关视频
06:23Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
8.5K
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.5K
相关概念视频
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Inflammation
61.4K
Overview
61.4K
